1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Medinova Diagnostic Services Limited

Medinova Diagnostic Services Limited

MEDINOV.BO
Medinova Diagnostic Services LimitedIN flagBombay Stock Exchange
43.45
INR
-0.56
- -
433.70MMarket Cap

Total Valuation

Medinova Diagnostic Services Limited carries a market capitalization of 433.70M, placing it among publicly traded companies globally. Its enterprise value stands at 396.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap433.70M
Enterprise Value396.30M

Share Statistics

Medinova Diagnostic Services Limited currently has 9.98M shares outstanding.

Shares Outstanding9.98M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Medinova Diagnostic Services Limited trades at a trailing price-to-earnings ratio of 18.64. The price-to-sales ratio is 4.05, and the price-to-book ratio stands at 4.03.

PE Ratio18.64
PS Ratio4.05
PB Ratio4.03
P/TBV Ratio-396.75
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Medinova Diagnostic Services Limited trades at an EV/EBITDA multiple of 11.63 and an EV/FCF ratio of 118.74. The EV/Sales ratio of 4.00 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.63 provides insight into valuation relative to core operating earnings.

EV / Sales4.00
EV / EBITDA11.63
EV / EBIT11.63
EV / FCF118.74

Financial Position

Medinova Diagnostic Services Limited maintains a current ratio of 1.48, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -4,801.92, indicating conservative leverage, while an interest coverage ratio of 7.20 demonstrates adequate ability to service its debt obligations.

Current Ratio1.48
Quick Ratio1.30
Debt / Equity-4,801.92
Debt / EBITDA1.17
Interest Coverage7.20

Financial Efficiency

Medinova Diagnostic Services Limited posts a return on equity of 21.62 and a return on invested capital of 67.98.

Return on Equity (ROE)21.62
Return on Assets (ROA)30.74
Return on Invested Capital (ROIC)67.98
Return on Capital Employed (ROCE)17.20
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover11.15

Taxes

Over the trailing twelve months, Medinova Diagnostic Services Limited has paid 8.97M in income taxes, reflecting an effective tax rate of 29.43.

Income Tax8.97M
Effective Tax Rate29.43

Stock Price Statistics

Medinova Diagnostic Services Limited's stock has gained approximately 13.0333% over the past 52 weeks. The 50-day moving average sits at 41.26, while the 200-day moving average is 39.92.

Beta (5Y)N/A
52-Week Price Change13.0333%
50-Day Moving Average41.26
200-Day Moving Average39.92
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Medinova Diagnostic Services Limited generated 99.10M in revenue and converted that into 21.52M in net income, yielding earnings per share of 2.16. EBITDA reached 34.07M, while operating income came in at 34.07M.

Revenue99.10M
Gross Profit85.17M
Operating Income34.07M
Pretax Income30.50M
Net Income21.52M
EBITDA34.07M
EBIT34.07M
Earnings Per Share (EPS)2.16

Balance Sheet

Medinova Diagnostic Services Limited holds 44.82M in cash and equivalents against 40.00M in total debt, resulting in a net debt position of 18.62M. Total book value stands at 99.57M, with working capital of 16.59M providing operational flexibility.

Cash & Cash Equivalents44.82M
Total Debt40.00M
Net Debt18.62M
Equity (Book Value)99.57M
Book Value Per Share9.97
Working Capital16.59M

Margins

Medinova Diagnostic Services Limited operates with a gross margin of 85.94, reflecting its pricing power and cost economics. The operating margin of 34.38 and net profit margin of 21.72 provide insight into operational efficiency.

Gross Margin85.94
Operating Margin34.38
Pretax Margin30.78
Profit Margin21.72
EBITDA Margin34.38

Scores

Medinova Diagnostic Services Limited posts an Altman Z-Score of 6.17, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.17